HEMISPHERX BIOPHARMA INC·4

Apr 19, 1:31 PM ET

PASCALE ADAM 4

4 · HEMISPHERX BIOPHARMA INC · Filed Apr 19, 2018

Insider Transaction Report

Form 4
Period: 2018-04-12
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2018-04-12+75,00075,000 total
    Exercise: $0.38From: 2018-04-12Exp: 2028-04-12Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This option is being awarded by the Board of Directors.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT